Evidence map›Paper›PMID 40094812›Full record

ArticleBrain : a journal of neurology2025

Activated αβ T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis.

Daniela Esser, Louisa Müller-Miny, Michael Heming, Manuela Paunovic, Martijn van Duijn, Ligia Abrante Cabrera, Katharina M Mair, Christine Strippel, Saskia Räuber, Justina Dargvainiene and 17 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Deciphering autoimmune encephalitis: Immune mechanisms, therapeutic paradigms, and global research trends.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  12. Review
  13. Autoimmune encephalitis.Nature reviews. Disease primers · 2025
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Daniela EsserInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel/Lübeck, Kiel 24103, Schleswig-Holstein, Germany.
Louisa Müller-MinyDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.
Michael HemingDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.
Manuela PaunovicDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam 3000 DR, The Netherlands.
Martijn van DuijnDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam 3000 DR, The Netherlands.ORCID 0000-0002-6654-994X
Ligia Abrante CabreraInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel/Lübeck, Kiel 24103, Schleswig-Holstein, Germany.
Katharina M MairDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna 1090, Austria.
Christine StrippelDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.
Saskia RäuberDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.ORCID 0000-0001-8901-5572
Justina DargvainieneInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel/Lübeck, Kiel 24103, Schleswig-Holstein, Germany.
Stjepana KovacDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.ORCID 0000-0002-2500-6893
Catharina C GrossDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.ORCID 0000-0002-4872-9189
Nina FransenDepartment of Pathology, Amsterdam UMC, Amsterdam 1098XH, The Netherlands.
Robin van SteenhovenDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam 3000 DR, The Netherlands.
Péter KörtvélyessyDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.ORCID 0000-0003-1262-6169
Werner StenzelDepartment of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 10117, Germany.
Romana HöftbergerDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna 1090, Austria.ORCID 0000-0002-5769-1100
Eric BindelsDepartment of Hematology, Erasmus MC University Medical Center, Rotterdam 3000 DR, The Netherlands.
Christian G BienDepartment of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Bielefeld 33501, North Rhine-Westphalia, Germany.ORCID 0000-0003-2225-8654
Heinz WiendlDepartment of Neurology and Neurophysiology, Medical Center-University of Freiburg, Freiburg 79104, Baden-Wuerttemberg, Germany.
Sven G MeuthDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.
Jan BauerDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna 1090, Austria.ORCID 0000-0001-5802-8047
Nico MelzerDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.ORCID 0000-0002-2420-701X
Maarten J TitulaerDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam 3000 DR, The Netherlands.ORCID 0000-0002-1033-3840
Frank LeypoldtInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel/Lübeck, Kiel 24103, Schleswig-Holstein, Germany.ORCID 0000-0002-8972-515X
Gerd Meyer Zu HörsteDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48143, North Rhine-Westphalia, Germany.ORCID 0000-0002-4341-4719
in cooperation with the EMC-AIE Study group

Funding

BMBF CONNECT GENERATE 2.0 01GM2208ADeutsche Forschungsgemeinschaft 90030376505Deutsche Forschungsgemeinschaft LE3064/2-1Deutsche Forschungsgemeinschaft ME4050/7-1DFG ME3050/12-1DFG ME4050/13-1DFG ME 4050/14-1 KFORDioraphte 2001 0403Dutch Epilepsy Foundation NEF 19-08EpilepsieNLERA-NET NEURON_BB-148 MICE-AEE-Rare Joint Transnational research supportGerman Ministry of Education and Research 01GM1908AGerman Ministry of Education and Research 01GM2208AHORIZON MSCA 2022 Doctoral Network 101119457-IgG4-TREATInterdisciplinary Center for Clinical Research (IZKF) of the medical faculty Münster MzH3/020/20IZKF of the medical faculty Münster SEED/016/21Stiftung Pathobiochemie of the German Society for Laboratory Medicine ID-PRECISIONUltraAIE
6 · The paper itself

Abstract

Anti-leucine-rich glioma inactivated-1 (LGI1) and anti-contactin-associated-protein-2 (CASPR2) autoimmune encephalitis (AIE) are common and characterized by pathogenic antibodies targeting neuronal autoantigens. However, the drivers of the antibody-secreting cells and involvement of T cells remain unresolved. We performed single-cell RNA sequencing of fresh CSF and parallel blood samples of 15 patients with LGI1-AIE (n = 9) and CASPR2-AIE (n = 6) compared with control patients [multiple sclerosis (n = 15) and idiopathic intracranial hypertension (n = 18)]. We validated our observations in independent cohorts using flow cytometry of CSF and blood. We confirmed autoantibody specificity using recombinant human monoclonal antibodies. In comparison to idiopathic intracranial hypertension and multiple sclerosis controls, we observed clonal CSF-specific antibody-secreting cell expansion in LGI1/CASPR2-AIE despite mostly normal CSF findings. Antibody-secreting cells were dominantly plasmablasts and transcribed IgG4 and IgG1/2 heavy chains. Expanded clones showed signs of affinity maturation and bound the respective neuronal autoantigen. Within CD4 and CD8 T-cell clusters, CD4 and CD8 central memory T cells were activated, clonally restricted and expanded. T-cell clones were often shared between CSF and blood. We also observed a shift of natural killer cells and loss of mucosa-associated invariant T (MAIT) cells in the CSF of LGI1-AIE and the blood of LGI1- and CASPR2-AIE compared with idiopathic intracranial hypertension and multiple sclerosis controls. MAIT-like T cells were detected in autopsied brains of LGI1- and CASPR2-AIE patients, and mice lacking MAIT cells displayed an increased antibody seroconversion and higher titres following active LGI1/CASPR2 immunization. Our data: (i) confirm the intrathecal antigen-specific plasma cell expansion in LGI1- and CASPR2-AIE in a large cohort of untreated AIE patients; (ii) suggest that activated and expanded central memory CD4 and CD8 T cells in the CSF participate in disease pathogenesis; and (iii) implicate invariant T-cell receptor-expressing lymphocytes in the brain, CSF and blood in disease pathogenesis.

Indexed as

Autoimmune Diseases of the Nervous SystemEncephalitisIntracellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsT-LymphocytesAdultAgedAutoantibodiesFemaleHumansMaleMiddle AgedYoung AdultAutoantibodiesCNTNAP2 protein, humanIntracellular Signaling Peptides and ProteinsLGI1 protein, humanMembrane ProteinsNerve Tissue Proteinsautoimmune encephalitiscontactin-associated protein 2flow cytometryleucin-rich glioma inactivated 1mucosa-associated invariant T cellssingle-cell transcriptomics

Identifiers

PMID40094812
PMCPMC12404778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.